Form 4: Tandem Diabetes Care Director Kathleen McGroddy-Goetz Reports Stock Transactions
SEC Form 4 Filing
Director Kathleen McGroddy-Goetz reports acquisition and disposal of Tandem Diabetes Care stock and restricted stock units.
Summary
- Kathleen McGroddy-Goetz, a director at Tandem Diabetes Care, filed a Form 4 detailing changes in her beneficial ownership of the company's securities.
- On May 24, 2024, she exercised restricted stock units (RSUs) converting 4,434 units into common stock at a price of $51.73.
- Following these transactions, McGroddy-Goetz directly owns 13,466 shares of Tandem Diabetes Care common stock.
- She also holds 4,387 restricted stock units, awarded on May 22, 2024, which will vest on the one-year anniversary of the grant date.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment.
Future Outlook
The restricted stock units awarded on May 22, 2024, will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
Industry Context
This is a routine disclosure of stock transactions by a company insider, as required by SEC regulations.
Key Dates
| Date | Description |
|---|---|
| 05/22/2024 | Award date of 4,387 restricted stock units. |
| 05/24/2024 | Date of RSU exercise and stock transaction. |
| 05/24/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.